1. Perspective: The Potential Role of Vasoactive Intestinal Peptide in Treating COVID-19;Javitt,2020
2. Anticipated pharmacological role of Aviptadil on COVID-19;Mukherjee;Environ Sci Pollut Res,2022
3. Aviptadil in acute respiratory distress syndrome associated with COVID-19 infection;Dewan;European Journal of Pharmaceutical and Medical Research,2022
4. Orphan Drug Designations and Approvals, USFDA. Vasoactive intestinal peptide and Aviptadil, Available on https://www.accessdata.fda.gov/scripts/opdlisting/oopd/listResult.cfm.
5. Orphan designation, European Medicines Agency. Aviptadil, Available on pages 1-3; Doc.Ref.: EMEA/COMP/187221/2008 https://www.ema.europa.eu/en/medicines/field_ema_web_categories%253Aname_field/Human/ema_group_types/ema_orphan?search_api_views_fulltext=Aviptadil.